Results 151 to 160 of about 80,998 (294)

Janus kinase and calcineurin‐inhibitor combination in anti‐MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Objectives Anti‐MDA5 dermatomyositis (anti‐MDA5 DM) is the most severe subtype of dermatomyositis, due to its pulmonary involvement. Current treatment involves corticosteroids and immunosuppressants, but variability in responses exists. This study aims to evaluate the efficacy and safety of Janus kinase (JAK)– and calcineurin–inhibitor ...
Valentine Pagis   +47 more
wiley   +1 more source

One Single Session to Sleep Them All? The Potential of Single‐Session Interventions for Insomnia

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Poor sleep and insomnia are pervasive public health concerns, with insomnia ranking as the second most prevalent mental health disorder in the general population. Moreover, insomnia is a significant predictor of subsequent depression and is frequently co‐occurring with other psychological difficulties.
Matteo Carpi   +2 more
wiley   +1 more source

Erratum: Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume [PDF]

open access: gold, 2017
Michael Berk   +14 more
openalex   +1 more source

Nitrated meat products are associated with mania in humans and altered behavior and brain gene expression in rats

open access: yesMolecular Psychiatry, 2018
Seva G. Khambadkone   +18 more
semanticscholar   +1 more source

Dysfunction of the rostral lateral septum GABAergic neurons induces mania-like behavior in male mice. [PDF]

open access: yesTransl Psychiatry
Zhou Y   +8 more
europepmc   +1 more source

Advanced Circadian Phase in Mania and Delayed Circadian Phase in Mixed Mania and Depression Returned to Normal after Treatment of Bipolar Disorder

open access: yesEBioMedicine, 2016
J. Moon   +13 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy